Avandia Debate "Skewed" By Pharmaceutical Company (Medical News Today)

Researchers claim that pharmaceutical company GlaxoSmithkline has tried to influence the debate on the safety of diabetes treatment drug Avandia, also known as rosiglitazone, which the company manufactures. A new study claims that more than nine out of ten scientists who backed the drug had financial links to the pharmaceutical industry. Researchers from the Mayo Clinic in Minnesota analysed ...